Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
That’s Nice 30
Sort By
Newest First
1 / 1
1 / 1
Collaboration
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-14
Mar 03, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12
Mar 02, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07
Mar 02, 2025
Continuous
The Future is Continuous: Accelerating the Shift in Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-08
Mar 02, 2025
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11
Mar 02, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13
Mar 02, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10
Mar 02, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09
Mar 02, 2025
Orphan Drugs
From Market Failures to Lifesaving Innovations: The Evolution of Orphan Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-06
Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04
Mar 02, 2025
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01
Mar 02, 2025
Microbiome
Harnessing the Human Microbiome: 30 Years of Discovery and Innovation in Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-02
Mar 02, 2025
Oncology
From Coley’s Toxins to mRNA: Reflecting on the History of Cancer Vaccines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-03
Mar 02, 2025
